OliX Pharmaceuticals Revenue

OliX Pharmaceuticals had revenue of 2.91B KRW in the quarter ending September 30, 2025, with 1,002.56% growth. This brings the company's revenue in the last twelve months to 10.18B, down -36.91% year-over-year. In the year 2024, OliX Pharmaceuticals had annual revenue of 5.68B, down -66.73%.

Revenue (ttm)

10.18B

Revenue Growth

-36.91%

P/S Ratio

236.28

Revenue / Employee

n/a

Employees

n/a

Market Cap

2,405.73B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	5.68B	-11.39B	-66.73%
Dec 31, 2023	17.06B	7.74B	83.09%
Dec 31, 2022	9.32B	5.65B	153.66%
Dec 31, 2021	3.67B	1.20B	48.50%
Dec 31, 2020	2.47B	1.34B	118.90%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	5,504.84B
Celltrion	3,895.99B
ALTEOGEN	202.18B
ABL Bio	88.44B
SK Biopharmaceuticals	675.41B
Yuhan	2,136.67B
LigaChem Biosciences	159.27B
Peptron	6.19B

Revenue Rankings